CD56(bright) natural killer cells expand and contract irrespective of CD25 antibody treatment in kidney allograft recipients.

Zenhaeusern, G; Hönger, G; Gasser, O; Steiger, J; Schaub, S; Hess, C

Zenhaeusern, G; Hönger, G; Gasser, O; Steiger, J; Schaub, S; Hess, C.

Scand J Immunol ; 69(5): 465-7, 2009 May.

Article in En | MEDLINE | ID: mdl-19508378

Subject(s)

Antibodies, Monoclonal/pharmacology; CD56 Antigen/immunology; Interleukin-2 Receptor alpha Subunit/immunology; Kidney Transplantation/immunology; Killer Cells, Natural/immunology; Adult; Aged; Female; Humans; Kidney Transplantation/methods; Killer Cells, Natural/cytology; Killer Cells, Natural/drug effects; Lymphocyte Count; Male; Middle Aged; Time Factors; Transplantation, Homologous

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Kidney Transplantation / CD56 Antigen / Interleukin-2 Receptor alpha Subunit / Antibodies, Monoclonal Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Scand J Immunol Year: 2009 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google